MICHAEL DAVID: Open Payments
NPI 1881318699 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,116 in 27 payments from 10 companies in 2025. Trend: 2023 $365 · 2024 $876 · 2025 $1,116
Food & beverage: $1,116
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $269 |
| SCPHARMACEUTICALS INC. | 7 | $236 |
| Ardelyx, Inc. | 9 | $149 |
| NxStage Medical, Inc. | 1 | $141 |
| Travere Therapeutics, Inc. | 1 | $118 |
| Amgen Inc. | 1 | $107 |
| Fresenius USA Marketing, Inc. | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $17 |
Products named: FUROSCIX, IBSRELA, JYNARQUE, NXSTAGE SYSTEM ONE, TAVNEOS, VELPHORO, Vanrafia, JARDIANCE.
Industry payments across VA — which companies pay providers there.
